Vastagbélrák: vizsgálatok itt: Csehország
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Where
- Olomouc, Prague
- Életkor
- 18 év and over
- People
- 430 worldwide
- Run by
- Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00 - 3. fázisTaking peoplePhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Where
- Brno, Hradec Králové, Olomouc, Prague
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT07228832 - No phaseTaking peopleMRD Monitoring in Colorectal Cancer Using ctDNA
- Where
- Brno
- Életkor
- 18 év and over
- People
- 60
- Run by
- Masaryk Memorial Cancer Institute
See details and how to joinNCT07895459 - 2. fázisTaking peopleA Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
- Where
- Brno-Stred, Hradec Králové, Prague, Prague 4
- Életkor
- 18 év and over
- People
- 390 worldwide
- Run by
- AbbVie
See details and how to joinNCT06820463 · EU 2024-512981-33-00 - 3. fázisNot yet taking people in CsehországStudy of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.
- Where
- Brno, Brno-Stred, Hořovice, Hradec Králové, Prague
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Genmab A/S
See details and how to join2026-525883-17-00 · EU 2026-525883-17-00 - 2/3. fázisTaking peopleA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Where
- Brno-Stred, Hradec Králové, Olomouc, Prague
- Életkor
- 18 év and over
- People
- 990 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07221357 · EU 2025-523224-45-00 - 2. fázisTaking peopleEvaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
- Where
- Prague
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Delcath Systems Inc.
See details and how to joinNCT06607458 - 3. fázisTaking peopleA Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination with FOLFOX versus Bevacizumab in Combination with FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer (HARMONi-GI3)
- Where
- Brno-Stred, Hradec Králové, Olomouc, Prague, Prague 2
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- Summit Therapeutics Inc.
See details and how to join2025-521587-35-00 · EU 2025-521587-35-00 - 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Brno-Stred, Olomouc, Prague
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00 - 1/2. fázisTaking peopleA Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
- Where
- Brno-Stred
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- SOTIO Biotech a.s.
See details and how to joinNCT07693751 · EU 2026-526235-19-00 - 3. fázisTaking peopleStudy of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Where
- Brno, Hradec Králové, Olomouc, Prague
- Életkor
- 18 év and over
- People
- 450 worldwide
- Run by
- Amgen
See details and how to joinNCT06252649 - 3. fázisTaking peopleSotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)
- Where
- Brno-Stred, Novy Hradec Kralove, Olomouc, Prague, Prague 10, Prague 5
- Életkor
- 18 év to 64 év
- People
- 241 worldwide
- Run by
- Amgen Inc.
See details and how to join2022-502352-31-00 · EU 2022-502352-31-00 - 2. fázisTaking peopleRandomized Study to Evaluate Melphalan/HDS Treatment Followed by Trifluridine–tipiracil plus Bevacizumab Versus Trifluridine–tipiracil plus Bevacizumab Alone in Metastatic Colorectal Cancer Patients
- Where
- Prague
- Életkor
- 18 év and over
- People
- 35 worldwide
- Run by
- Delcath Systems Inc.
See details and how to join2024-520356-24-00 · EU 2024-520356-24-00 - 2. fázisTaking peopleAn Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
- Where
- Brno-Stred, Hořovice, Novy Knin, Prague
- Életkor
- 18 év and over
- People
- 136 worldwide
- Run by
- NGM Biopharmaceuticals, Inc
See details and how to joinNCT07033026 · EU 2025-521730-28-00 - 3. fázisTaking peopleStudy of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- Where
- Hradec Králové, Nový Jičín, Prague
- Életkor
- 18 év and over
- People
- 892 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05855200 · EU 2023-503265-27-00 - No phaseTaking peopleRectal Cancer CTC Trial
- Where
- Olomouc, Ostrava
- Életkor
- 18 év and over
- People
- 120
- Run by
- University Hospital Ostrava
See details and how to joinNCT07194616